Report Detail
Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3475589 |
- 16 July, 2019 |
- Global |
- 103 Pages |
- QYResearch |
- Other
Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
In 2018, the global Musculoskeletal Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
AbbVie
Johnson & Johnson
Sanofi
Merck
Novartis
Eli Lilly
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
Amgen
Takeda Pharmaceutical
Daiichi Sankyo
LG Life Sciences
Astellas
Samsung Bioepis
Zosano Pharma
Taisho Pharmaceutical
3SBio
Market segment by Type, the product can be split into
Biologics
Small Molecules
Other
Market segment by Application, split into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Musculoskeletal Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Biologics
- 1.4.3 Small Molecules
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Osteoarthritis
- 1.5.3 Osteoporosis
- 1.5.4 Psoriatic Arthritis
- 1.5.5 Ankylosing Spondylitis
- 1.5.6 Fibromyalgia
- 1.5.7 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Musculoskeletal Disorders Therapeutics Market Size
- 2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Regions
- 2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Musculoskeletal Disorders Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Musculoskeletal Disorders Therapeutics Market Size by Manufacturers
- 3.1.1 Global Musculoskeletal Disorders Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Musculoskeletal Disorders Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Musculoskeletal Disorders Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 5.2 Musculoskeletal Disorders Therapeutics Key Players in United States
- 5.3 United States Musculoskeletal Disorders Therapeutics Market Size by Type
- 5.4 United States Musculoskeletal Disorders Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 6.2 Musculoskeletal Disorders Therapeutics Key Players in Europe
- 6.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Type
- 6.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Application
7 China
- 7.1 China Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 7.2 Musculoskeletal Disorders Therapeutics Key Players in China
- 7.3 China Musculoskeletal Disorders Therapeutics Market Size by Type
- 7.4 China Musculoskeletal Disorders Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 8.2 Musculoskeletal Disorders Therapeutics Key Players in Japan
- 8.3 Japan Musculoskeletal Disorders Therapeutics Market Size by Type
- 8.4 Japan Musculoskeletal Disorders Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 9.2 Musculoskeletal Disorders Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type
- 9.4 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application
10 India
- 10.1 India Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 10.2 Musculoskeletal Disorders Therapeutics Key Players in India
- 10.3 India Musculoskeletal Disorders Therapeutics Market Size by Type
- 10.4 India Musculoskeletal Disorders Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
- 11.2 Musculoskeletal Disorders Therapeutics Key Players in Central & South America
- 11.3 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type
- 11.4 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.1.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.1.5 Pfizer Recent Development
- 12.2 AbbVie
- 12.2.1 AbbVie Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.2.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.2.5 AbbVie Recent Development
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.3.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.3.5 Johnson & Johnson Recent Development
- 12.4 Sanofi
- 12.4.1 Sanofi Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.4.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.4.5 Sanofi Recent Development
- 12.5 Merck
- 12.5.1 Merck Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.5.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.5.5 Merck Recent Development
- 12.6 Novartis
- 12.6.1 Novartis Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.6.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.6.5 Novartis Recent Development
- 12.7 Eli Lilly
- 12.7.1 Eli Lilly Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.7.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.7.5 Eli Lilly Recent Development
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.8.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.8.5 AstraZeneca Recent Development
- 12.9 Boehringer Ingelheim
- 12.9.1 Boehringer Ingelheim Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.9.4 Boehringer Ingelheim Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.9.5 Boehringer Ingelheim Recent Development
- 12.10 F. Hoffmann-La Roche
- 12.10.1 F. Hoffmann-La Roche Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Musculoskeletal Disorders Therapeutics Introduction
- 12.10.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
- 12.10.5 F. Hoffmann-La Roche Recent Development
- 12.11 Amgen
- 12.12 Takeda Pharmaceutical
- 12.13 Daiichi Sankyo
- 12.14 LG Life Sciences
- 12.15 Astellas
- 12.16 Samsung Bioepis
- 12.17 Zosano Pharma
- 12.18 Taisho Pharmaceutical
- 12.19 3SBio
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Musculoskeletal Disorders Therapeutics. Industry analysis & Market Report on Musculoskeletal Disorders Therapeutics is a syndicated market report, published as Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Musculoskeletal Disorders Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
